Evaluation of additives on reversed-phase chromatography of monoclonal antibodies using a 1000 Å stationary phase.
Acid additives
Mabs
Monoclonal antibodies
Reversed phase LC
Journal
Journal of chromatography. A
ISSN: 1873-3778
Titre abrégé: J Chromatogr A
Pays: Netherlands
ID NLM: 9318488
Informations de publication
Date de publication:
11 Jan 2020
11 Jan 2020
Historique:
received:
26
07
2019
revised:
18
09
2019
accepted:
20
09
2019
pubmed:
2
10
2019
medline:
31
3
2020
entrez:
2
10
2019
Statut:
ppublish
Résumé
A wide pore (1000 Å) diphenyl stationary phase was evaluated for the analysis of monoclonal antibodies (mAbs), comparing a conventional mobile phase of acetonitrile-water containing overall 0.1% trifluoracetic acid (TFA) with a similar mobile phase incorporating in addition 5% butanol. Alternatively, TFA was replaced by ammonium formate (AF) buffer (pH 3.0) and by methane sulfonic acid. Addition of 5% butanol to the mobile phase reduces the minimum temperature at which suitable UV analysis of the mAbs can be obtained from about 70 °C with TFA alone to about 60 °C thus potentially improving column lifetime and reducing the possibility of sample degradation. AF buffers produce satisfactory UV sensitivity at 70 °C and have the advantage of reducing signal suppression in mass spectrometry (MS). Some peak tailing was noted in comparison with TFA separations. Methane sulfonic acid at the same molar concentration as TFA produced the best chromatographic peaks, maintaining reasonable UV sensitivity down to 50 °C, also giving acceptable results even at only 3 mM concentration of the additive. The good results with this additive were attributed to its stronger acidity and consequent suppression of the ionisation of column silanols. Surprisingly, peak response (as measured by the size of the peaks) was rather poorly correlated with the peak capacity of the gradient analysis. A possible explanation is self-deactivation of active column sites by a portion of the sample.
Identifiants
pubmed: 31570192
pii: S0021-9673(19)30956-2
doi: 10.1016/j.chroma.2019.460562
pii:
doi:
Substances chimiques
Acetonitriles
0
Antibodies, Monoclonal
0
Buffers
0
Formates
0
formic acid
0YIW783RG1
Bevacizumab
2S9ZZM9Q9V
Rituximab
4F4X42SYQ6
acetonitrile
Z072SB282N
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
460562Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.